Skip to content
Screener

Staar Surgical STAA Shares (Diluted)

Shares (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
2.4B+0.9%
Bausch Health Companies logo
Bausch Health CompaniesBHC
372.8M+0.9%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
15.4M+31.0%
IAR
Integra LifeSciencesIART
78.2M+1.9%
Schering-Plough logo
Schering-PloughSGP
19.9M+794%
Glaukos logo
GlaukosGKOS
58.8M+2.8%

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.15B-13.0%
Enterprise value$1.06B-11.7%
P/S-1.9×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Reported directly by Staar Surgical in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Staar Surgical’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0000718937-26-000023
Line itemThree Months Ended / April 3, 2026Three Months Ended / March 28, 2025
Provision (benefit) for income taxes3,012(275)
Net income (loss)$5,206$(54,211)
Net income (loss) per share:
Basic$0.10$(1.10)
Diluted$0.10$(1.10)
Weighted average shares outstanding:
Basic49,90849,344
Diluted50,90049,344

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Staar Surgical's shares (diluted)?
Staar Surgical (STAA) reported shares (diluted) of 50.9M in Q1 2026.
How has Staar Surgical's shares (diluted) changed year-over-year?
Staar Surgical's shares (diluted) increased by 3.2% year-over-year, from 49.3M to 50.9M.
What is the long-term trend for Staar Surgical's shares (diluted)?
Over 4 years (2021 to 2025), Staar Surgical's shares (diluted) has grown at a 0.2% compound annual growth rate (CAGR), from 197.8M to 199M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Staar Surgical's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude